ACCC developing care coordination model for Medicaid patients with lung cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Association of Community Cancer Centers has initiated a three-year initiative focused on developing an optimal care coordination model for Medicaid patients with lung cancer throug

Funding and support for this project is provided by a grant from the Bristol-Myers Squibb Foundation.

Phase one, conducted throughout 2017, focuses on research. Drawing on a literature review and environmental scan, extensive on-site information gathered at five cancer programs that served as development sites, and with the insight and guidance of the project’s Advisory Committee and Technical Expert Panel, ACCC developed a beta version of the care coordination model.

The OCCM builds directly on the Multidisciplinary Care Assessment Tool created by the National Cancer Institute Community Cancer Centers Program, a 2007-2014 NCI-funded initiative. The model, which is designed to be used at cancer programs of all resource levels, focuses on 13 areas of care for patients with lung cancer.

  • Patient Access to Care

  • Prospective Multidisciplinary Case Planning

  • Financial, Transportation, and Housing

  • Management of Co-morbid Conditions

  • Care Coordination

  • Treatment Team Integration

  • Electronic Health Records (EHR) and Patient Access to Information

  • Survivorship Care

  • Supportive Care

  • Tobacco Cessation

  • Clinical Trials

  • Physician Engagement

  • Quality Measurement and Improvement

During the second phase, ACCC would test the beta optimal care coordination model. To select testing sites, ACCC conducted a comprehensive, competitive application process. Seven ACCC member cancer programs have been selected to test the model by conducting quality improvement initiatives in one or more of the 13 OCCM assessment areas listed above:

  • Cowell Family Cancer Center (Munson Healthcare) – Traverse City, MI

  • Northwest Medical Specialties – Tacoma, WA

  • Ascension Wheaton Franciscan Cancer Care – Milwaukee, WI

  • Florida Hospital Memorial Medical Center – Daytona Beach, FL

  • Genesis Cancer Care Center – Zanesville, OH

  • Advocate Lutheran General Hospital Cancer Care Program – Park Ridge, IL

  • Southern Ohio Medical Center – Portsmouth, OH

The third phase, testing the model, will be from October 2017-September 2018. Data and outcomes from this phase will be used to further refine and modify the OCCM to ensure that it is a practical guide for cancer programs interested in advancing patient-centered, multidisciplinary, coordinated care for their lung cancer patients on Medicaid.

YOU MAY BE INTERESTED IN

Twenty years ago, the discovery of epidermal growth factor receptor mutations as drivers of tumorigenesis and viable targets for therapeutic intervention marked the beginning of a new era in lung cancer diagnosis and treatment. Since then, the field has made remarkable progress towards developing more effective targeted treatments and immunotherapies that have significantly improved patient outcomes and survival.

Login